2 型糖尿病患者的重要结局 : 钠 - 葡萄糖协同转运蛋白 - 2 抑制剂和胰高血糖素样肽 - 1 受体激动剂的范例.
关键词: Type 2 diabetes mellitus fixed ratio combination of basal insulin/glucagon-like peptide-1 receptor agonists glucagon-like peptide-1 receptor agonists health-related quality of life patient-important outcomes sodium-glucose cotransporter-2 inhibitors
Mesh : Humans Diabetes Mellitus, Type 2 / drug therapy diagnosis blood Sodium-Glucose Transporter 2 Inhibitors / therapeutic use adverse effects Glucagon-Like Peptide-1 Receptor / agonists metabolism Quality of Life Treatment Outcome Hypoglycemic Agents / therapeutic use adverse effects Blood Glucose / metabolism drug effects Risk Factors Glycemic Control / adverse effects Incretins / therapeutic use adverse effects Biomarkers / blood Patient Reported Outcome Measures Risk Assessment Health Status Glucagon-Like Peptide-1 Receptor Agonists
来 源:
DOI:10.1177/14791641241269743
PDF(Pubmed)